{"nctId":"NCT01022580","briefTitle":"Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia","startDateStruct":{"date":"2010-01"},"conditions":["Bronchopulmonary Dysplasia"],"count":511,"armGroups":[{"label":"Infasurf surfactant (ONY, Inc.)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Infasurf surfactant (ONY, Inc.)"]},{"label":"Sham (No Treatment)","type":"SHAM_COMPARATOR","interventionNames":["Drug: Sham (No Treatment)"]}],"interventions":[{"name":"Infasurf surfactant (ONY, Inc.)","otherNames":["Treatment"]},{"name":"Sham (No Treatment)","otherNames":["Control"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* \\<=28 0/7 weeks gestational age\n* Day of life 7-14\n* Intubated and mechanically ventilated\n* Plan to treat with inhaled nitric oxide\n\nExclusion Criteria:\n\n* Serious congenital malformations or chromosomal abnormalities\n* Life expectancy \\<7 days from enrollment\n* Clinically unstable\n* Less tha 48 hours since last dose surfactant\n* Ability to obtain 36 week primary outcome information is unlikely","healthyVolunteers":false,"sex":"ALL","minimumAge":"7 Days","maximumAge":"14 Days","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Survival Without BPD at 36 Weeks Post Menstrual Age.","description":"BPD was diagnosed as need for respiratory support with either positive pressure and/or oxygen as evaluated by physiological oxygen/flow reduction.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"79","spread":null},{"groupId":"OG001","value":"82","spread":null}]}]}]},{"type":"SECONDARY","title":"Survival Without BPD at 40 Weeks","description":"BPD was diagnosed as need for respiratory support with either positive pressure and/or oxygen as evaluated by physiological oxygen/flow reduction.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"148","spread":null},{"groupId":"OG001","value":"140","spread":null}]}]}]},{"type":"SECONDARY","title":"Respiratory Outcomes of TOLSURF Infants at 1 Year Corrected Age","description":"Evaluation of respiratory outcome through the first 12 months after birth. questionnaires were administered by phone at 3,6,9 and 12 months to determine respiratory resource use (medications, home support, and hospitalization) No Pulmonary Morbidity (NoPM) was reported for infants who had no resource use in any quarter and Persistent PM was reported for infants having resource use in 3 or 4 quarters.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null},{"groupId":"OG001","value":"118","spread":null}]},{"measurements":[{"groupId":"OG000","value":"54","spread":null},{"groupId":"OG001","value":"47","spread":null}]},{"measurements":[{"groupId":"OG000","value":"74","spread":null},{"groupId":"OG001","value":"75","spread":null}]}]}]},{"type":"SECONDARY","title":"Pulmonary Outcomes Through 2 Years of Age","description":"Evaluation of pulmonary outcome at 24 months of age. Evaluation of persistent wheezing based on reported wheezing during both first and second year of life.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"91","spread":null},{"groupId":"OG001","value":"98","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Neurodevelopmental Impairment (NDI) at 2 Years.","description":"At 24 months corrected age, children underwent neuropsychological testing with the Bayley Scales of Infant Development-Third Edition (Bayley-3), and composite cognitive, language, and motor scores were collected as well as subscale scores in receptive and expressive speech and fine and gross motor. Infants with greater than one impairment as identified by testing were classified as having neurodevelopmental impairment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null},{"groupId":"OG001","value":"32","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":29,"n":252},"commonTop":["Sepsis","PDA Requiring Treatment","IVH New or Worsened","ROP Class 4-5 or surgery","NEC"]}}}